DB
MJN

Dmitry Balyasny’s Mead Johnson Nutrition Company MJN Stock Holding History

Dmitry Balyasny’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-109,600
Closed -$7.75M – 1898
2016
Q4 		$7.75M Sell
109,600
-142,484
-57% -$10.6M 0.04% 559
2016
Q3 		$136K Buy
252,084
+52,084
+26% +$4.44M ﹤0.01% 903
2016
Q2 		$18.1M Buy
+200,000
New +$16.9M 0.12% 234
2014
Q2 		– Sell
-100,000
Closed -$8.31M – 849
2014
Q1 		$8.31M Buy
+100,000
New +$8.11M 0.09% 263

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dmitry Balyasny's MJN Position: Q1 2017 in Review

Dmitry Balyasny sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 399,375 shares — an estimated $28.3M sold.

Dmitry Balyasny first reported a position in MJN in Q1 2014 and held it in 9 quarters. The position peaked at $71.8M in Q2 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Dmitry Balyasny reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Dmitry Balyasny sold 399,375 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $28.3M.
  • Dmitry Balyasny first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 9 quarters.
  • Dmitry Balyasny's Mead Johnson Nutrition Company position peaked at $71.8M in Q2 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.